ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Renal dysfunction"

  • 2016 American Transplant Congress

    Liver Recipient with Renal Dysfunction: Liver Only or Simultaneous Liver-Kidney Transplant?

    K. Yadav, T. Pruett, R. Kandaswamy, W. Payne, L. Zhang, S. Chinnakotla.

    University of Minnesota, Minneapolis, MN.

    Background: The OPTN listing criteria for Simultaneous liver-kidney transplant (SLK) are not well defined. There are concerns about rising numbers of SLKs, which take kidneys…
  • 2016 American Transplant Congress

    The UK Kidney Donor Risk Index Score Predicts the Development of TRAS Post Deceased Donor Transplantation.

    M. Willicombe, A. Baheerathan, S. Moser, A. McLean, M. Hammady, W. Gedroyc, D. Taube.

    Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    Introduction: Transplant renal artery stenosis (TRAS) is a heterogeneous disorder with different subtypes and aetiologies, which include traditional cardiovascular and transplant specific risk factors. Whether…
  • 2016 American Transplant Congress

    The UKKDRI Score Predicts Outcomes of Deceased Donor Transplantation Using a Steroid Sparing Immunosuppressive Protocol.

    A. Wardle, M. Willicombe, D. Goodall, A. McLean, D. Taube.

    Imperial College REnal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    The UK kidney donor risk-index (UKKDRI) was developed to provide a simplistic clinical tool to help determine quality of an allograft and aid informed consent.…
  • 2016 American Transplant Congress

    Adenovirus Infection in Kidney Transplant Recipients: Report of a Case Series.

    C. Simancas-Ruiz, L. Marino-Vazquez, A. Meraz-Muñoz, A. Nuñez-Abreu, R. Rivera-Marfil, N. Uribe-Uribe, J. Alberu, L. Morales-Buenrostro.

    Nephrology, Transplant and Pathology, National Institute of Medical Sciences and Nutrition SZ, México, DF, Mexico.

    Introduction: In kidney transplant recipients, the incidence of adenovirus infection is 4.1%, usually occur in the first three months after transplantation. Patients may have viral…
  • 2016 American Transplant Congress

    Association of Smoking Habits with Comorbidity 15 Years After Liver Transplantation.

    S. Pischke,3 M. Lege,1 L. Fischer,2 U. Herden,2 A. Lohse,3 B. Nashan,2 M. Sterneck.1

    1University Transplant Center, University Hospital Hamburg Eppendorf, Hamburg, Germany; 2Department of Hepatobiliary Surgery and Transplantation, University Hospital Hamburg Eppendorf, Hamburg, Germany; 3Department of Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany.

    Background and aimsThe survival rate of liver transplant (OLT) recipients has strongly improved over the last years. Here we investigate the association between long term…
  • 2016 American Transplant Congress

    Identification of Donor HLA-Specific Antibodies as a Risk Factor for Graft Dysfunction and Failure Following BK Virus Associated Nephropathy.

    E. Abuhelaiqa, S. Salvatore, J. Lee, J. Lee, V. Sharma, T. Muthukumar, S. Seshan, M. Suthanthiran, D. Dadhania.

    Transplantation Medicine, Weill Cornell Medicine, New York, NY.

    Background: BK virus associated nephropathy (BKVN) has emerged as a significant cause of graft dysfunction and graft failure. Identification of risk factors for graft dysfunction…
  • 2016 American Transplant Congress

    Slipping Through the Cracks: Late Onset BK Viremia.

    J. Gandhi,1 M. Mackenzie,1 D. DeWolfe,2 F. Cardarelli,3 M. Pavlakis,3 C. Tan.1,4

    1Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA; 2Division of Nephrology, BIDMC, Boston, MA; 3The Transplant Institute, BIDMC, Boston, MA; 4Division of Infectious Disease, BIDMC, Boston, MA.

    Introduction: Most studies indicate that viremia caused by BK virus (BKV), the step preceding BKV associated nephropathy (BKVN) in kidney transplant recipients (KTRs), occurs within…
  • 2016 American Transplant Congress

    Conversion from Tacrolimus to Belatacept in Pancreas Transplant Alone Recipients with Chronic Kidney Disease.

    A. Sharfuddin, J. Chen, M. Yaqub, T. Taber, J. Powelson, D. Mishler, M. Goble, J. Fridell, O. Adebiyi, M. Mujtaba.

    Medicine/Nephrology & Surgery/Transplant, Indiana University, Indianapolis.

    Background: CNI toxicity is a well known risk factor for chronic kidney disease and ESRD in organ transplants. We report our experience in converting Pancreas…
  • 2016 American Transplant Congress

    Levels of VEGF-C, PLGF and Follistatin at 12 Months Post Transplantation Are Associated with Increased Risk for Long Term Progressive Renal Dysfunction.

    G. Dreyer,1 J. de Fijter,1 D. Briscoe,2 K. Daly,2 M. Reinders.1

    1Nephrology, LUMC, Leiden, Netherlands; 2Transplantation Research Center, Boston Children's Hospital, Boston, MA.

    *contributed equallyIntroduction Integrity of the microvasculature is critical for long term survival after solid organ transplantation. We hypothesize that biomarkers of endothelial injury and repair…
  • 2016 American Transplant Congress

    AT1R Antibodies at 1-Year Negatively Impact 5-Year Native Renal Function in Liver Transplant Recipients.

    J. O'Leary,1 A. Philippe,2 H. Heidecke,2 R. Freeman,1 L. Jennings,1 R. Catar,2 G. Klintmalm,1 D. Dragun.2

    1Baylor Simmons Transplant Insttute, Baylor University Medical Center, Dallas, TX; 2Internal Medicine, Charite, Berlin, Germany.

    Angiotensin II Type-1 Receptor (AT1R) antibodies have been associated with pulmonary hypertension, renal allograft loss, and fibrosis progression in liver allograft recipients especially if combined…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 17
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences